DataFax in use

Since its inception in 1991, DataFax has been used in hundreds of studies worldwide. A few examples are listed below.

Published Reports

Clinical Trials registered at

  • Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand NCT00006327
  • Outcome Reduction With Initial Glargine Intervention (ORIGIN) NCT00069784
  • Heart Outcomes Prevention Evaluation-2 Study (HOPE-2) NCT00106886
  • Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma NCT00132301
  • Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand NCT00203749
  • Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial NCT00337181
  • Facial Lipoatrophy Correction Experience With SCULPTRA (“FACES” Study) NCT00360932
  • Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS) NCT00371891
  • Heart Outcomes Prevention Evaluation-3 (HOPE3) NCT00468923
  • Photoselective Vaporization of the Prostate Compared to Transurethral Resection of the Prostate for the Treatment of Benign Hyperplasia of the Prostate (PVP) NCT00527371
  • CSP #563 – Prazosin and Combat Trauma PTSD (PACT) NCT00532493
  • Hyperbaric Oxygen Therapy (HBOT) for Chronic Diabetic Lower Limb Ulcers NCT00621608
  • Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 NCT00685412
  • Pipeline for Uncoilable or Failed Aneurysms (PUFS) NCT00777088
  • A Prospective, Immunogenicity Surveillance Registry of Erythropoiesis Stimulating Agent (ESA) With Subcutaneous Exposure in Thailand NCT00799019
  • Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis ( Pharmacokinetics of Standard First and Second Line Anti-TB Drugs in the Lung and Lesions of Subjects Elected for Resection Surgery) NCT00816426
  • A Study of the Effect of a Chronic Disease Management System on Diabetes Care Within Multidisciplinary Primary Care Practices in Ontario NCT00914706
  • Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis (COAT) NCT01075152
  • Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate NCT01080716
  • Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants (HIV-001) NCT01082692
  • Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults NCT01142362
  • Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100 NCT01188850
  • National Cancer Institute, Epidemiology of Burkitt Lymphoma in East African Children or Minors (EMBLEM) NCT01196520
  • Multi-vitamins, HAART and HIV/AIDS in Uganda NCT01228578
  • A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People (APOLLO) NCT01259297
  • Preventing the Spread of Malaria in Mali (Malaria Transmission Blocking Assay Development and Gametocyte Carriage in a Vaccine Testing Site in Mali) NCT01360112
  • The PeerCARE Study (Peer Community-based Assistant in Retention): Effect of Peer Health Workers on People Living With HIV Not on Antiretroviral Therapy NCT01366690
  • Trial for Improvement of Near Vision in Presbyopic Patients NCT01373580
  • A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001 NCT01403155
  • A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus NCT01405885

Study Web Sites

  • National Cancer Institute, Epidemiology of Burkitt Lymphoma in East African Children or Minors - EMBLEM
  • Linking with multiple state cancer registries for safety surveillance study - Forteo Patient Registry
  • Laboratory of Immunogenetics, Systems Biology of Malaria Immunity in Mali and Tanzania - NIAID
  • Laboratory of Immunology and Vaccinology, Immunology and Epidemiology of Malaria in Maliand Tanzania – NIAID
  • Laboratory of Immunoregulation, Hepatitis B and HIV Co-infection in Uganda - NIAID
  • Laboratory of Immunoregulation, Malaria Surveillance in Rakai, Uganda - NIAID
  • Laboratory of Malaria and Vector Research, International Studies on Malaria and Entomology - NIAID

Contact Us Today!

If you have any questions about our software or services please contact us by phone or click the Contact Us button to send a message.

Contact Us Contact Us or call: 1-206-686-5134